We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$20.9B
AUM Growth
+$1.18B
Cap. Flow
-$95.1M
Cap. Flow %
-0.46%
Top 10 Hldgs %
24.18%
Holding
1,443
New
92
Increased
575
Reduced
559
Closed
58

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$49.3M
2
IQV icon
IQVIA
IQV
+$42.7M
3
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$34.7M
4
COR icon
Cencora
COR
+$32.7M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$22.7M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$61.8M
2
PGR icon
Progressive
PGR
+$60.9M
3
ANET icon
Arista Networks
ANET
+$23.1M
4
PATH icon
UiPath
PATH
+$22.5M
5
EBAY icon
eBay
EBAY
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 23.2%
2 Healthcare 11.29%
3 Financials 10.11%
4 Consumer Discretionary 8.76%
5 Industrials 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARES icon
751
Ares Management
ARES
$28.1B
$898K ﹤0.01%
5,762
-82
-1% -$11.9K
XIFR
752
XPLR Infrastructure LP
XIFR
$1.04B
$894K ﹤0.01%
32,380
– –
TRNO icon
753
Terreno Realty
TRNO
$7.58B
$884K ﹤0.01%
13,234
+3,782
+40% +$254K
JBHT icon
754
JB Hunt Transport Services
JBHT
$25.9B
$880K ﹤0.01%
5,108
+95
+2% +$16K
AIT icon
755
Applied Industrial Technologies
AIT
$12.4B
$876K ﹤0.01%
3,928
+403
+11% +$82.1K
CRNX icon
756
Crinetics Pharmaceuticals
CRNX
$8.88B
$876K ﹤0.01%
17,144
-807
-4% -$41.6K
VRNA
757
DELISTED
Verona Pharma
VRNA
$870K ﹤0.01%
30,251
-4,565
-13% -$112K
XLC icon
758
State Street Communication Services Select Sector SPDR ETF
XLC
$22.5B
$869K ﹤0.01%
9,616
+201
+2% +$17.3K
BEN icon
759
Franklin Resources
BEN
$16.8B
$868K ﹤0.01%
43,090
-4,583
-10% -$98.7K
SOLV icon
760
Solventum
SOLV
$15.3B
$861K ﹤0.01%
12,343
-11,196
-48% -$673K
WELL icon
761
Welltower
WELL
$173B
$858K ﹤0.01%
6,702
+543
+9% +$63.4K
NYT icon
762
New York Times
NYT
$12.6B
$858K ﹤0.01%
15,407
+32
+0.2% +$1.72K
CHRW icon
763
C.H. Robinson
CHRW
$20.5B
$856K ﹤0.01%
7,760
+774
+11% +$75.2K
JHG
764
DELISTED
Janus Henderson
JHG
$856K ﹤0.01%
22,480
+40
+0.2% +$1.45K
FELE icon
765
Franklin Electric
FELE
$4.66B
$847K ﹤0.01%
8,077
+202
+3% +$20.2K
VIS icon
766
Vanguard Industrials ETF
VIS
$7.94B
$846K ﹤0.01%
3,254
+46
+1% +$11.3K
ESGV icon
767
Vanguard ESG US Stock ETF
ESGV
$12.8B
$844K ﹤0.01%
+8,301
New +$814K
CPK icon
768
Chesapeake Utilities
CPK
$3.28B
$842K ﹤0.01%
6,782
+904
+15% +$106K
VDE icon
769
Vanguard Energy ETF
VDE
$9.9B
$841K ﹤0.01%
6,868
+426
+7% +$53.3K
ITCI
770
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$839K ﹤0.01%
11,469
-1,289
-10% -$96.9K
FDS icon
771
Factset
FDS
$10B
$838K ﹤0.01%
1,822
-199
-10% -$84.5K
HWM icon
772
Howmet Aerospace
HWM
$109B
$837K ﹤0.01%
8,353
+199
+2% +$18K
QTWO icon
773
Q2 Holdings
QTWO
$3.78B
$836K ﹤0.01%
10,479
-183
-2% -$12.9K
YUMC icon
774
Yum China
YUMC
$15.7B
$834K ﹤0.01%
18,528
-1,314
-7% -$43.7K
RWR icon
775
State Street SPDR Dow Jones REIT ETF
RWR
$1.9B
$834K ﹤0.01%
7,812
– –
29 30
31
32 33

Similar funds

EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
SC
Savant Capital Rockford, Illinois $20.7B AUM 19.76% 1-Year Est. Return

Glenmede Trust's Q3 2024 Portfolio in Review

As of Q3 2024, Glenmede Trust held 1,443 positions worth $20.9B, up 6% from $19.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Glenmede Trust's Q3 2024 filing shows 92 new, 575 increased, 559 reduced and 58 closed positions. Its largest new stake was NOV: 859,708 shares worth $13.7M. The largest sale was Vertex Pharmaceuticals, an estimated $61.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Glenmede Trust's largest Q3 2024 buy was NOV: 859,708 shares worth $13.7M.
  • Glenmede Trust added most to Merck in Q3 2024, an estimated $49.3M increase.
  • Glenmede Trust's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $61.8M.
  • Glenmede Trust fully exited Pacira BioSciences in Q3 2024, selling an estimated $10.5M.
  • Glenmede Trust's ten largest holdings make up 24% of its $20.9B portfolio in Q3 2024.
  • Glenmede Trust opened 92 new positions and closed 58 in Q3 2024.
  • Glenmede Trust's portfolio value rose 6% quarter-over-quarter to $20.9B.

Based on Glenmede Trust's 13F filing for Q3 2024, filed 13 Nov 2024.